82 results
Page 2 of 5
8-K
EX-99.1
gsidfhyf
23 Nov 20
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
gbsgpwo iznsdzh2wtp
4 Aug 20
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
jegzu4 xzh
6 May 20
Results of Operations and Financial Condition
4:09pm
8-K
EX-99.1
7ktstk13
6 Feb 20
Positive results from part 1 of the Phase 1a/b clinical study ofEDP-514 in healthy subjects
4:14pm
8-K
EX-99.1
8wc4oyezy 3959
21 Nov 19
Results of Operations and Financial Condition
4:05pm
8-K
EX-99.1
ebf667nnm6zl0kp gk
6 Aug 19
Royalty revenue for the quarter was $44.4 million
4:06pm
8-K
EX-99.1
oninvjjr
7 May 19
Data from Phase 2a RSV program anticipated mid-2019 and Phase 2a NASH program by the end of third quarter of calendar 2019
4:04pm
8-K
EX-99.1
5moiwpei
6 Feb 19
Royalty revenue for the quarter increased to $69.9 million
4:05pm